Atlas Trials

Ropivacaine Use in Femoral Nerve Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Clinical trial NCT04834440 · UNKNOWN

Trial details

NCT number
NCT04834440
Sponsor
Healthpoint Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Postoperative Pain
Start date
2021-05-01
Primary completion
2021-09-30
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.